Dissociated non-steroidal glucocorticoids: tuning out untoward effects

Bibliography

• ADDISON T: On the constitutional and local effects of disease of the suprarenal capsules. Samuel Highley, London (1855).
   Google Scholar
• BRUGGEMEIER RW, MILLER DD, WITIAK DT: Chapter 23: cholesterol, adrenocorticoids, and sex hormones. In: Principles of Medicinal Chemistry, 4th Edn. Foye WO, Lemke TL, Williams DA (Eds). Williams & Wilkins, Baltimore (1995):444-498.
   Google Scholar
• SHOPPEE CS: Chemistry of Steroids, 2nd Edn. London, Butterworth (1964):245-146.
   Google Scholar
• RAGAN C: The undesirable side-effects, withdrawal symptoms and contraindications of the use of cortisone and ACTH in rheumatic diseases. Bull. Rheum. Dis. (1950) 1(3):5-6.
   Google Scholar
• PARENTE L: The development of synthetic glucocorticoids. In: Milestones in drug therapy: glucocorticoids. Goulding NJ, Flower RJ (Eds). Basel, Switzerland, Birkauser Verlag (2001):35-51.
   Google Scholar
• SCHIMMER BP, PARKER KL: Chapter 59: adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones. In: Goodman & Gilman’s The Pharmacological Basis of Therapeutics, Nineth Edition. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (Eds). McGraw-Hill, Health Professions Division, New York (1996) 1459-1485.
   Google Scholar
• NEWELL-PRICE J, BERTAGNA X, GROSSMAN AB, NIEMAN LK: Cushing's syndrome. Lancet (2006) 367(9522):1605-1617.
   PubMed Web of Science ®Google Scholar
• WILLI SM, KENNEDY A, WALLACE P, GANAWAY E, ROGERS NL, GARVERY WT: Troglitazone antagonizes metabolic effects of glucocorticoids in humans:e on glucose tolerance, insulin sensitivity, suppression of free fatty acids and leptin. Diabetes (2002) 51:2895-2902.
   PubMed Web of Science ®Google Scholar
• O'BRIEN RM, NOISIN EL, SUWANICHKUL A et al.: Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes. Mol. Cell. Biol. (1995) 15(3):1747-1758.
   PubMed Web of Science ®Google Scholar
• JANTZEN HM, STRÄHLE U, GLOSS B et al.: Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell (1987) 49(1):29-38.
   PubMed Web of Science ®Google Scholar
• GRENIER J, TOMKIEWICZ C, TROUSSON A, RAJKOWSKI KM, SCHUMACHER M, MASSAAD C: Identification by microarray analysis of aspartate aminotransferase and glutamine synthetase as glucocorticoid target genes in a mouse Schwann cell line. J. Steroid Biochem. Mol. Biol. (2005) 97(4):342-352.
   Google Scholar
• REICHARDT HM, KAESTNER KH, TUCKERMANN J et al.: DNA binding of the glucocorticoid receptor is not essential for survival. Cell (1998) 93(4):531-541.
   PubMed Web of Science ®Google Scholar
• TUCKERMANN JP, REICHARDT HM, ARRIBAS R, RICHTER KH, SCHUTZ G, ANGEL P: The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J. Cell Biol. (1999) 147(7):1365-1370.
   PubMed Web of Science ®Google Scholar
• GARSIDE H, STEVENS H, FARROW S et al.: Glucocorticoid ligands specify different interactions with NF-κB by allosteric effects on the glucocorticoid receptor DNA binding domain. J. Biol. Chem. (2004) 279(48):50050-50059.
   PubMed Web of Science ®Google Scholar
• BUETTI E, KÜHNEL B: Distinct sequence elements involved in the glucocorticoid regulation of the mouse mammary tumor virus promoter identified by linker scanning mutagenesis. J. Mol. Biol. (1989) 190:379-389.
   Google Scholar
• LEFEBVRE P, FORMSTECHER P, ROUSSEAU GG, LUSTENBERGER P, DAUTREVAUX M: Improvement in glucocorticoid receptor binding affinity concomitant to shift from antagonist to agonist activity in a series of 17 β-carboxamide derivatives of dexamethasone. J. Steroid Biochem. (1989) 33(4A):557-563.
   Google Scholar
• WELKER P, LIPPERT U, NURNBERG W, KRUGER-KRASAGAKES S, MOLLER A, CZARNETZKI BM: Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells. Int. Arch. Allergy Immunol. (1996) 109(2):110-115.
   PubMed Web of Science ®Google Scholar
• TUBARO et al.: Agent Actions 17:347-349 (1985); similar reference: BOURIN MC, DELESCLUSE C, FURSTENBERGER G et al.: Effect of phorbol esters on guinea pig skin in vivo. Carcinogenesis. (1982) 3(6):671-676.
   Google Scholar
• DIAMANDSTONE et al.: Anal. Biochemistry (1966) 16:395-401.
   Google Scholar
• NEUMANN et al.: Arzneim. Forsch. (Drug Res.) (1984) 34:296-318.
   Google Scholar
• SCHACKE H, SCHOTTELIUS A, DOCKE WD et al.: Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects. Proc. Natl. Acad. Sci. (2004) 101(1):227-232.
   PubMed Web of Science ®Google Scholar
• BARKER M, CLACKERS M, DEMAINE DA et al.: Design and synthesis of new nonsteroidal glucocorticoid modulators through application of an “agreement docking” method. J. Med. Chem. (2005) 48:4507-4510.
   Google Scholar
• BARKER M, CLACKERS M, COPLEY R et al.: Dissociated nonsteroidal glucocorticoid receptor modulators: discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series. J. Med. Chem. (2006) 49(14):4216-4231.
   PubMed Web of Science ®Google Scholar
• BRZOZOWSKI AM, PIKE AC, DAUTER Z et al.: Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 389:753-758.
   PubMed Web of Science ®Google Scholar
• BETAGERI R, ZHANG Y, ZINDELL RM et al.: Trifluoromethyl group as a pharmacophore: effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand. Bioorg. Med. Chem. Lett. (2005) 15:4761-4769.
   Google Scholar
• MACDIARMID F, WANG D, DUNCAN LJ, PUROHIT A, GHILCHICK MW, REED MJ: Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor-α. Mol. Cell. Endocrinol. (1994) 106(1-2):17-21.
   PubMed Web of Science ®Google Scholar
• SHAH N, SCANLAN TS: Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands. Bioorg. Med. Chem. Lett. (2004) 14(20):5199-5203.
   PubMed Web of Science ®Google Scholar
• HANNAH J, KELLY K, PATCHETT AA: Substituted pyrazolo corticoids as topical anti-inflammatory agents. J. Med. Chem. (1975) 18(2):168-172.
   Google Scholar
• HIRSCHMANN R, STEINBERG NG, BUCHSCHACHER P et al.: Synthesis and structure of steroidal 4-pregneno[3,2-c] pyrazoles. A novel class of potent anti-inflammatory steroids. J. Am. Chem. Soc. (1963) 85(1):120-122.
   Web of Science ®Google Scholar
• SCANLAN TS: Selective glucocorticoid receptor modulators. 230th ACS National Meeting (Aug 28 – Sept 1, Washington DC) (2005) Abstr. MEDI 238.
   Google Scholar
• THOMPSON CF, QURAISHI N, ALI A et al.: Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacy. Bioorg. Med. Chem. Lett. (2005) 15(8):2163-2167.
   PubMed Web of Science ®Google Scholar
• SMITH CJ, ALI A, BALKOVEC JM et al.: Novel ketal ligands for the glucocorticoid receptor: in vitro and in vivo activity. Bioorg. Med. Chem. Lett. (2005) 15(11):2926-2931.
   Google Scholar
• ALI A, THOMPSON CF, BALKOVEC JM et al.: Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity. J. Med. Chem. (2004) 47(10):2441-2452.
   PubMedGoogle Scholar
• KYM PR, KORT ME, COGHLAN MJ et al.: Nonsteroidal selective glucocorticoid modulators: the effect of C-10 substitution on receptor selectivity and functional potency of 5-allyl-2,5-dihydro-2,2,4-tri- methyl-1H-[1]benzopyran[3,4-f]quinolines. J. Med. Chem. (2003) 46:1016-1030.
   PubMed Web of Science ®Google Scholar
• COGHLAN MJ, JACOBSON PB, LANE B et al.: A novel anti-inflammatory maintains glucocorticoid efficacy with reduced side effects. Mol. Endocrinol. (2003) 17:860-869.
   PubMed Web of Science ®Google Scholar
• ELMORE SW, PRATT JK, COGHLAN MJ et al.: Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators. Bioorg. Med. Chem. Lett. (2004) 14:1721-1727.
   PubMed Web of Science ®Google Scholar
• WANG JC, SHAH N, PANTOJA C et al.: Novel arylpyrazole compounds selectively modulate glucocorticoid receptor regulatory activity. Genes Dev. (2006) 20(6):689-699.
   PubMed Web of Science ®Google Scholar
• OLIVIER S, CLOSE P, CASTERMANS E et al.: Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-κB inhibition and gene expression signature. Mol. Pharmacol. (2006) 69(5):1615-1623.
   PubMed Web of Science ®Google Scholar
• BRAY JD, ZHANG Z, WINNEKER RC, LYTTLE CR: Regulation of gene expression by PRA-910, a novel progesterone receptor modulator, in T47D cells. Steroids (2003) 68(10-13):995-1003.
   Google Scholar
• KARST H, BERGER S, TURIAULT M, TRONCHE F, SCHUTZ G, JOELS M: Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc. Natl. Acad. Sci. (2005) 102(52):19204-19207.
   PubMed Web of Science ®Google Scholar
• SCHLICHTER R, KELLER AF, DE ROO M, BRETON JD, INQUIMBERT P, POISBEAU P: Fast nongenomic effects of steroids on synaptic transmission and role of endogenous neurosteroids in spinal pain pathways. J. Mol. Neurosci. (2006) 28(1):33-51.
   Google Scholar
• MANAVATHI B, KUMAR R: Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin. J. Cell. Physiol. (2006) 207(3):594-604.
   PubMedGoogle Scholar